Journal ArticleDOI
Quantitative structure–activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries
Hai Pham-The,Gerardo M. Casañola-Martin,Karel Diéguez-Santana,Nam Nguyen-Hai,N T Ngoc,L Vu-Duc,Huong Le-Thi-Thu +6 more
TLDR
This study illustrates the power of ML-based QSAR approaches for the screening and discovery of potent, isoform-selective HDACIs.Abstract:
Histone deacetylases (HDAC) are emerging as promising targets in cancer, neuronal diseases and immune disorders. Computational modelling approaches have been widely applied for the virtual screening and rational design of novel HDAC inhibitors. In this study, different machine learning (ML) techniques were applied for the development of models that accurately discriminate HDAC2 inhibitors form non-inhibitors. The obtained models showed encouraging results, with the global accuracy in the external set ranging from 0.83 to 0.90. Various aspects related to the comparison of modelling techniques, applicability domain and descriptor interpretations were discussed. Finally, consensus predictions of these models were used for screening HDAC2 inhibitors from four chemical libraries whose bioactivities against HDAC1, HDAC3, HDAC6 and HDAC8 have been known. According to the results of virtual screening assays, structures of some hits with pair-isoform-selective activity (between HDAC2 and other HDACs) were revealed. This study illustrates the power of ML-based QSAR approaches for the screening and discovery of potent, isoform-selective HDACIs.read more
Citations
More filters
Journal ArticleDOI
Small molecule HDAC inhibitors: Promising agents for breast cancer treatment.
TL;DR: In conclusion, HDACs have shown desirable effects on breast cancer, especially when they are used in combination with other anticancer agents, and more multicenter and randomized Phase III studies are expected to be conducted pushing promising new therapies closer to the market.
Journal ArticleDOI
Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity
Doan Thanh Hieu,Duong Tien Anh,Pham-The Hai,Le-Thi-Thu Huong,Eun Jae Park,Jeong Eun Choi,Jong Soon Kang,Phan Thi Phuong Dung,Sang-Bae Han,Nguyen Hai Nam +9 more
TL;DR: Detailed investigation on the estimation of absorption, distribution, metabolism, excretion, and toxicity (ADMET) suggested that compounds 4g, 6c, and 6g, while showing potent HDAC2 inhibitory activity and cytotoxicity, also potentially displayed ADMET characteristics desirable to be expected as promising anticancer drug candidates.
Journal ArticleDOI
Evaluation of pyrrole-2,3-dicarboxylate derivatives: Synthesis, DFT analysis, molecular docking, virtual screening and in vitro anti-hepatic cancer study
Iqbal Azad,Asif Jafri,Tahmeena Khan,Yusuf Akhter,Arshad,Firoj Hassan,Naseem Ahmad,Abdul Rahman Khan,Malik Nasibullah +8 more
TL;DR: Pyrrole-2,3-dicarboxylate derivatives synthesized in this study significantly inhibited the growth of HepG2 cells in a dose-dependent manner and may be proven to be novel therapeutic candidates to cure cancer.
Journal ArticleDOI
Conformal prediction of HDAC inhibitors.
Ulf Norinder,Ulf Norinder,J. Jesús Naveja,J. Jesús Naveja,Edgar López-López,Daniel Mucs,José L. Medina-Franco +6 more
TL;DR: This work introduces a novel approach for epigenetic quantitative structure–activity relationship (QSAR) modelling using conformal prediction and discusses the development of models for 11 sets of inhibitors of histone deacetylases, which are one of the major epigenetic target families that have been screened.
References
More filters
Journal ArticleDOI
Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities.
Cheng Wang,Leonhard M. Henkes,Leah B. Doughty,Min He,Difei Wang,Franz-Josef Meyer-Almes,Yi-Qiang Cheng,Yi-Qiang Cheng +7 more
TL;DR: Thailandepsins represent new naturally produced HDAC inhibitors that are promising for anticancer drug development and can be beneficial towards certain types of cell lines.
Journal ArticleDOI
Trend of histone deacetylase inhibitors in cancer therapy: isoform selectivity or multitargeted strategy.
Lei Zhang,Yantao Han,Qixiao Jiang,Chunbo Wang,Xuehong Chen,Xiaoguang Li,Fuming Xu,Yuqi Jiang,Qiang Wang,Wenfang Xu +9 more
TL;DR: In order to gain insight into HDACI design, the strategies and achievements of the two diverse methods are reviewed.
Journal ArticleDOI
Novel Inhibitors of Human Histone Deacetylase (HDAC) Identified by QSAR Modeling of Known Inhibitors, Virtual Screening, and Experimental Validation
Hao Tang,Xiang Simon Wang,Xi Ping Huang,Bryan L. Roth,Kyle V. Butler,Alan P. Kozikowski,Mira Jung,Alexander Tropsha +7 more
TL;DR: This study illustrates the power of the combined QSAR-VS method as a general approach for the effective identification of structurally novel bioactive compounds.
Journal ArticleDOI
Histone deacetylase 2 (HDAC2) regulates chromosome segregation and kinetochore function via H4K16 deacetylation during oocyte maturation in mouse.
Pengpeng Ma,Richard M. Schultz +1 more
TL;DR: Hdac2 is implicate as the major HDAC that regulates global histone acetylation during oocyte development and HDAC2 is largely responsible for the deacetylation of H4K16 during maturation, and the results provide additional support that histone deacetyation that occurs during oocytes maturation is critical for proper chromosome segregation.
Journal ArticleDOI
Towards selective inhibition of histone deacetylase isoforms: what has been achieved, where we are and what will be next.
Florian Thaler,Ciro Mercurio +1 more
TL;DR: This Minireview aims at surveying recent developments as well as the design, synthesis and biological characterization of isoform‐selective derivatives of HDAC inhibitors and their derivatives.